Plasminogen is a complement inhibitor

Journal of Biological Chemistry

Volumn 287, Issue 22, 2012, Pages 18831-18842

  Barthel, Diana ^a   Schindler, Susann ^a   Zipfel, Peter F ^a,b  

^a HANS KNÖLL INSTITUTE   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASCADE SYSTEMS; CLASSICAL PATHWAY; CLEAVAGE PRODUCTS; COFACTORS; EXTRACELLULAR MATRIX COMPONENTS; FIBRIN CLOTS; FLUID-PHASE; HEMOLYTIC ASSAYS; LYSINE RESIDUES; PATHOGENIC MICROBES; SHEEP ERYTHROCYTES; SINGLE CHAINS; TISSUE PENETRATIONS;

AMINO ACIDS; COAGULATION; DEGRADATION; IONIC STRENGTH; TISSUE;

BINDING SITES;

COMPLEMENT; COMPLEMENT COMPONENT C3B; COMPLEMENT COMPONENT C3D; COMPLEMENT COMPONENT C5; COMPLEMENT FACTOR H; COMPLEMENT FACTOR I; PLASMIN; PLASMINOGEN;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; BINDING COMPETITION; BINDING SITE; COMPLEMENT ALTERNATIVE PATHWAY; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; CONTROLLED STUDY; HEMOLYSIS; IONIC STRENGTH; MOLECULAR WEIGHT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEIN FUNCTION; PROTEIN PROTEIN INTERACTION;

COMPLEMENT INACTIVATING AGENTS; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; PLASMINOGEN; SURFACE PLASMON RESONANCE;

ORYCTOLAGUS CUNICULUS; OVIS ARIES; VERTEBRATA;

EID: 84861566815     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M111.323287     Document Type: Article

References (54)

1. Sottrup-Jensen, L., Zajdel, M., Claeys, H., Petersen, T. E., and Magnusson, S. (1975) Amino-acid sequence of activation cleavage site in plasminogen: homology with "pro" part of prothrombin. Proc. Natl. Acad. Sci. U.S.A. 72, 2577-2581
2. Castellino, F. J., and McCance, S. G. (1997) The kringle domains of human plasminogen. Ciba Found. Symp. 212, 46-60; discussion 60-45
3. Miyashita, C., Wenzel, E., and Heiden, M. (1988) Plasminogen: a brief introduction into its biochemistry and function. Haemostasis 18, Suppl. 1, 7-13 (Pubitemid 18062024)
4. Lähteenmäki, K., Edelman, S., and Korhonen, T. K. (2005) Bacterial metastasis: the host plasminogen system in bacterial invasion. Trends Microbiol. 13, 79-85 (Pubitemid 40174867)
5. Lähteenmäki, K., Kuusela, P., and Korhonen, T. K. (2000) Plasminogen activation in degradation and penetration of extracellular matrices and basement membranes by invasive bacteria. Methods 21, 125-132 (Pubitemid 32896758)
6. Myöhänen, H., and Vaheri, A. (2004) Regulation and interactions in the activation of cell-associated plasminogen. Cell. Mol. Life Sci. 61, 2840-2858 (Pubitemid 40064331)
7. Amara, U., Rittirsch, D., Flierl, M., Bruckner, U., Klos, A., Gebhard, F., Lambris, J. D., and Huber-Lang, M. (2008) Interaction between the coagulation and complement system. Adv. Exp. Med. Biol. 632, 71-79
8. Wolberg, A. S., and Campbell, R. A. (2008) Thrombin generation, fibrin clot formation and hemostasis. Transfus. Apher. Sci. 38, 15-23
9. Wolberg, A. S. (2007) Thrombin generation and fibrin clot structure. Blood Rev. 21, 131-142
10. Cesarman-Maus, G., and Hajjar, K. A. (2005) Molecular mechanisms of fibrinolysis. Br. J. Haematol. 129, 307-321 (Pubitemid 40646889)
11. Degen, J. L., Bugge, T. H., and Goguen, J. D. (2007) Fibrin and fibrinolysis in infection and host defense. J. Thromb. Haemost. 5, Suppl. 1, 24-31 (Pubitemid 46958813)
12. Moroz, L. A., and Gilmore, N. J. (1976) Fibrinolysis in normal plasma and blood: evidence for significant mechanisms independent of the plasminogen- plasmin system. Blood 48, 531-545
13. Petersen, T. E., Martzen, M. R., Ichinose, A., and Davie, E. W. (1990) Characterization of the gene for human plasminogen, a key proenzyme in the fibrinolytic system. J. Biol. Chem. 265, 6104-6111
14. Walport, M. J. (2001) Complement. First of two parts. N. Engl. J. Med. 344, 1058-1066
15. Walport, M. J. (2001) Complement. Second of two parts. N. Engl. J. Med. 344, 1140-1144
16. Zipfel, P. F., Mihlan, M., and Skerka, C. (2007) The alternative pathway of complement: a pattern recognition system. Adv. Exp. Med. Biol. 598, 80-92
17. Zipfel, P. F., and Skerka, C. (2009) Complement regulators and inhibitory proteins. Nat. Rev. Immunol. 9, 729-740
18. Thurman, J. M., and Holers, V. M. (2006) The central role of the alternative complement pathway in human disease. J. Immunol. 176, 1305-1310 (Pubitemid 43134269)
19. Heinen, S., Hartmann, A., Lauer, N., Wiehl, U., Dahse, H. M., Schirmer, S., Gropp, K., Enghardt, T., Wallich, R., Hälbich, S., Mihlan, M., Schlötzer-Schrehardt, U., Zipfel, P. F., and Skerka, C. (2009) Factor H-related protein 1 (CFHR-1) inhibits complement C5 convertase activity and terminal complex formation. Blood 114, 2439-2447
20. Zipfel, P. F., Skerka, C., Hellwage, J., Jokiranta, S. T., Meri, S., Brade, V., Kraiczy, P., Noris, M., and Remuzzi, G. (2002) Factor H family proteins: on complement, microbes and human diseases. Biochem. Soc. Trans. 30, 971-978 (Pubitemid 36002390)
21. Józsi, M., and Zipfel, P. F. (2008) Factor H family proteins and human diseases. Trends Immunol. 29, 380-387
22. Gigli, I., Fujita, T., and Nussenzweig, V. (1979) Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator. Proc. Natl. Acad. Sci. U.S.A. 76, 6596-6600 (Pubitemid 10163445)
23. Zipfel, P. F. (2009) Complement and immune defense: from innate immunity to human diseases. Immunol. Lett. 126, 1-7
24. Peerschke, E. I., Yin, W., and Ghebrehiwet, B. (2008) Platelet mediated complement activation. Adv. Exp. Med. Biol. 632, 81-91
25. Pillemer, L., Ratnoff, O. D., Blum, L., and Lepow, I. H. (1953) The inactivation of complement and its components by plasmin. J. Exp. Med. 97, 573-589
26. Taylor, F. B., Jr., and Ward, P. A. (1967) Generation of chemotactic activity in rabbit serum by plasminogen-streptokinase mixtures. J. Exp. Med. 126, 149-158
27. Ward, P. A. (1967) A plasmin-split fragment of C′3 as a new chemotactic factor. J. Exp. Med. 126, 189-206
28. Amara, U., Flierl, M. A., Rittirsch, D., Klos, A., Chen, H., Acker, B., Brückner, U. B., Nilsson, B., Gebhard, F., Lambris, J. D., and Huber-Lang, M. (2010) Molecular intercommunication between the complement and coagulation systems. J. Immunol. 185, 5628-5636
29. Seya, T., Nagasawa, S., Matsukura, M., Hasegawa, H., and Atkinson, J. P. (1985) Generation of C3d,g and C3d by urokinase-treated plasma in association with fibrinolysis. Complement 2, 165-174 (Pubitemid 16213819)
30. Polley, M. J., and Nachman, R. (1978) The human complement system in thrombin-mediated platelet function. J. Exp. Med. 147, 1713-1726 (Pubitemid 8372963)
31. Hallström, T., Jarva, H., Riesbeck, K., and Blom, A. M. (2007) Interaction with C4b-binding protein contributes to nontypeable Haemophilus influenzae serum resistance. J. Immunol. 178, 6359-6366 (Pubitemid 46717420)
32. Hallström, T., Zipfel, P. F., Blom, A. M., Lauer, N., Forsgren, A., and Riesbeck, K. (2008) Haemophilus influenzae interacts with the human complement inhibitor factor H. J. Immunol. 181, 537-545
33. Barthel, D., Singh, B., Riesbeck, K., and Zipfel, P. F. (2012) Haemophilus influenzae uses the surface protein E to acquire human plasminogen and to evade innate immunity. J. Immunol. 188, 379-385
34. Kunert, A., Losse, J., Gruszin, C., Hühn, M., Kaendler, K., Mikkat, S., Volke, D., Hoffmann, R., Jokiranta, T. S., Seeberger, H., Moellmann, U., Hellwage, J., and Zipfel, P. F. (2007) Immune evasion of the human pathogen Pseudomonas aeruginosa: elongation factor Tuf is a factor H and plasminogen binding protein. J. Immunol. 179, 2979-2988
35. Kraiczy, P., Skerka, C., Kirschfink, M., Brade, V., and Zipfel, P. F. (2001) Immune evasion of Borrelia burgdorferi by acquisition of human complement regulators FHL-1/reconectin and Factor H. Eur. J. Immunol. 31, 1674-1684 (Pubitemid 32547329)
36. Kraiczy, P., Skerka, C., Kirschfink, M., Zipfel, P. F., and Brade, V. (2001) Mechanism of complement resistance of pathogenic Borrelia burgdorferi isolates. Int. Immunopharmacol. 1, 393-401 (Pubitemid 32197538)
37. Seling, A., Siegel, C., Fingerle, V., Jutras, B. L., Brissette, C. A., Skerka, C., Wallich, R., Zipfel, P. F., Stevenson, B., and Kraiczy, P. (2010) Functional characterization of Borrelia spielmanii outer surface proteins that interact with distinct members of the human factor H protein family and with plasminogen. Infect. Immun. 78, 39-48
38. Brissette, C. A., Haupt, K., Barthel, D., Cooley, A. E., Bowman, A., Skerka, C., Wallich, R., Zipfel, P. F., Kraiczy, P., and Stevenson, B. (2009) Borrelia burgdorferi infection-associated surface proteins ErpP, ErpA, and ErpC bind human plasminogen. Infect. Immun. 77, 300-306
39. Zipfel, P. F., Hallström, T., Hammerschmidt, S., and Skerka, C. (2008) The complement fitness factor H: role in human diseases and for immune escape of pathogens, like pneumococci. Vaccine 26, Suppl. 8, I67-I74
40. Agarwal, V., Asmat, T. M., Luo, S., Jensch, I., Zipfel, P. F., and Hammer-schmidt, S. (2010) Complement regulator Factor H mediates a two-step uptake of Streptococcus pneumoniae by human cells. J. Biol. Chem. 285, 23486-23495
41. Bergmann, S., Rohde, M., Chhatwal, G. S., and Hammerschmidt, S. (2004) Characterization of plasmin(ogen) binding to Streptococcus pneumoniae. Indian J. Med. Res. 119, (suppl.) 29-32 (Pubitemid 39004442)
42. Haupt, K., Reuter, M., van den Elsen, J., Burman, J., Hälbich, S., Richter, J., Skerka, C., and Zipfel, P. F. (2008) The Staphylococcus aureus protein Sbi acts as a complement inhibitor and forms a tripartite complex with host complement Factor H and C3b. PLoS Pathog. 4, e1000250
43. Poltermann, S., Kunert, A., von der Heide, M., Eck, R., Hartmann, A., and Zipfel, P. F. (2007) Gpm1p is a factor H-, FHL-1-, and plasminogen-binding surface protein of Candida albicans. J. Biol. Chem. 282, 37537-37544
44. Luo, S., Poltermann, S., Kunert, A., Rupp, S., and Zipfel, P. F. (2009) Immune evasion of the human pathogenic yeast Candida albicans: Pra1 is a Factor H, FHL-1 and plasminogen binding surface protein. Mol. Immunol. 47, 541-550
45. Sun, H. (2006) The interaction between pathogens and the host coagulation system. Physiology 21, 281-288
46. Skerka, C., Hellwage, J., Weber, W., Tilkorn, A., Buck, F., Marti, T., Kampen, E., Beisiegel, U., and Zipfel, P. F. (1997) The human factor H-related protein 4 (FHR-4). A novel short consensus repeat-containing protein is associated with human triglyceride-rich lipoproteins. J. Biol. Chem. 272, 5627-5634 (Pubitemid 27102389)
47. Weber, S., Lottspeich, F., and Köhl, J. (1995) An epitope of elongation factor Tu is widely distributed within the bacterial and archaeal domains. J. Bacteriol. 177, 11-19
48. Levi, M., van der Poll, T., and Büller, H. R. (2004) Bidirectional relation between inflammation and coagulation. Circulation 109, 2698-2704 (Pubitemid 38737913)
49. Luo, S., Hartmann, A., Dahse, H. M., Skerka, C., and Zipfel, P. F. (2010) Secreted pH-regulated antigen 1 of Candida albicans blocks activation and conversion of complement C3. J. Immunol. 185, 2164-2173
50. Zipfel, P. F., Würzner, R., and Skerka, C. (2007) Complement evasion of pathogens: common strategies are shared by diverse organisms. Mol. Immunol. 44, 3850-3857 (Pubitemid 47332624)
51. Hallström, T., Haupt, K., Kraiczy, P., Hortschansky, P., Wallich, R., Skerka, C., and Zipfel, P. F. (2010) Complement regulator-acquiring surface protein 1 of Borrelia burgdorferi binds to human bone morphogenic protein 2, several extracellular matrix proteins, and plasminogen. J. Infect. Dis. 202, 490-498
52. Berge, A., and Sjöbring, U. (1993) PAM, a novel plasminogen-binding protein from Streptococcus pyogenes. J. Biol. Chem. 268, 25417-25424 (Pubitemid 23358145)
53. Kraiczy, P., Rossmann, E., Brade, V., Simon, M. M., Skerka, C., Zipfel, P. F., and Wallich, R. (2006) Binding of human complement regulators FHL-1 and factor H to CRASP-1 orthologs of Borrelia burgdorferi. Wien. Klin. Wochenschr. 118, 669-676 (Pubitemid 44953969)
54. Lasser, E. C., Slivka, J., Lang, J. H., Kolb, W. P., Lyon, S. G., Hamblin, A. E., and Nazareno, G. (1979) Complement and coagulation: causative considerations in contrast catastrophes. AJR Am. J. Roentgenol. 132, 171-176 (Pubitemid 9093476)